{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:09:54Z","timestamp":1793394594327,"version":"4.5.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.idc.2022.07.004","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T19:44:41Z","timestamp":1667245481000},"page":"897-909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Uses of Procalcitonin as a Biomarker in Critical Care Medicine"],"prefix":"10.1016","volume":"36","author":[{"given":"Ryan C.","family":"Maves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chukwunyelu H.","family":"Enwezor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.idc.2022.07.004_bib1","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.idc.2022.07.004_bib2","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/CCM.0000000000004863","article-title":"The Association Between Antibiotic Delay Intervals and Hospital Mortality Among Patients Treated in the Emergency Department for Suspected Sepsis","volume":"49","author":"Taylor","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.idc.2022.07.004_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1757-7241-17-67","article-title":"The Systemic Inflammatory Response Syndrome (SIRS) in acutely hospitalised medical patients: a cohort study","volume":"17","author":"Comstedt","year":"2009","journal-title":"Scand J Trauma Resusc Emerg Med"},{"issue":"11","key":"10.1016\/j.idc.2022.07.004_bib4","doi-asserted-by":"crossref","first-page":"e1144","DOI":"10.1097\/CCM.0000000000005090","article-title":"Likelihood of Bacterial Infection in Patients Treated With Broad-Spectrum IV Antibiotics in the Emergency Department","volume":"49","author":"Shappell","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.idc.2022.07.004_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fcimb.2019.00056","article-title":"Evaluation of the Magicplex Sepsis Real-Time Test for the Rapid Diagnosis of Bloodstream Infections in Adults","volume":"9","author":"Zboromyrska","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"10.1016\/j.idc.2022.07.004_bib6","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1097\/CCM.0000000000003658","article-title":"Enhanced Performance of Next-Generation Sequencing Diagnostics Compared With Standard of Care Microbiological Diagnostics in Patients Suffering From Septic Shock","volume":"47","author":"Grumaz","year":"2019","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.idc.2022.07.004_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0014-5793(84)80839-X","article-title":"The complete sequence of human preprocalcitonin","volume":"167","author":"Le Moullec","year":"1984","journal-title":"FEBS Lett"},{"issue":"8844","key":"10.1016\/j.idc.2022.07.004_bib8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0140-6736(93)90277-N","article-title":"High serum procalcitonin concentrations in patients with sepsis and infection","volume":"341","author":"Assicot","year":"1993","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.idc.2022.07.004_bib9","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1210\/en.2003-0854","article-title":"In\u00a0vitro and in\u00a0vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue","volume":"144","author":"Linscheid","year":"2003","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.idc.2022.07.004_bib10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.chest.2016.04.010","article-title":"Procalcitonin as an Early Marker of the Need for Invasive Respiratory or Vasopressor Support in Adults With Community-Acquired Pneumonia","volume":"150","author":"Self","year":"2016","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.idc.2022.07.004_bib11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.annemergmed.2008.01.003","article-title":"Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia","volume":"52","author":"Huang","year":"2008","journal-title":"Ann Emerg Med"},{"issue":"10","key":"10.1016\/j.idc.2022.07.004_bib12","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1097\/CCM.0b013e3182257445","article-title":"Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia","volume":"39","author":"Ramirez","year":"2011","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.idc.2022.07.004_bib13","doi-asserted-by":"crossref","first-page":"R88","DOI":"10.1186\/cc10087","article-title":"Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study","volume":"15","author":"Bloos","year":"2011","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.idc.2022.07.004_bib14","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/cc12787","article-title":"Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients","volume":"17","author":"Schuetz","year":"2013","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.idc.2022.07.004_bib15","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/CCM.0000000000002321","article-title":"Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study","volume":"45","author":"Schuetz","year":"2017","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.idc.2022.07.004_bib16","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1378\/chest.07-1456","article-title":"A\u00a0comparative study of community-acquired pneumonia patients admitted to the ward and the ICU","volume":"133","author":"Restrepo","year":"2008","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.idc.2022.07.004_bib17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/cid\/civ1214","article-title":"Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia","volume":"62","author":"Gadsby","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2022.07.004_bib18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.diagmicrobio.2016.06.008","article-title":"The potential of molecular diagnostics and serum procalcitonin levels to change the antibiotic management of community-acquired pneumonia","volume":"86","author":"Gilbert","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2022.07.004_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/cid\/cix317","article-title":"Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia","volume":"65","author":"Self","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2022.07.004_bib20","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/thoraxjnl-2020-214896","article-title":"Severe respiratory viral infection induces procalcitonin in the absence of bacterial pneumonia","volume":"75","author":"Gautam","year":"2020","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.idc.2022.07.004_bib21","first-page":"10","article-title":"Prognostic Value of Procalcitonin and C-Reactive Protein in 1608 Critically Ill Patients with Severe Influenza Pneumonia","author":"Carbonell","year":"2021","journal-title":"Antibiotics (Basel)"},{"issue":"7","key":"10.1016\/j.idc.2022.07.004_bib22","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.idc.2022.07.004_bib23","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1164\/rccm.201910-1970LE","article-title":"Procalcitonin Is Useful for Evaluating Patients with Ambiguous Presentation and for Early Discontinuation of Antibiotics in Community-acquired Pneumonia","volume":"201","author":"Schuetz","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.idc.2022.07.004_bib24","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1097\/CCM.0000000000004547","article-title":"Procalcitonin Is Not an Adequate Tool for Antimicrobial De-Escalation in Sepsis","volume":"48","author":"Maves","year":"2020","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.idc.2022.07.004_bib25","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/cid\/ciy1054","article-title":"Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial","volume":"69","author":"Yahav","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2022.07.004_bib26","article-title":"Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by enterobacterales: a randomized, controlled trial: authors' response","author":"Molina","year":"2021","journal-title":"Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"19","key":"10.1016\/j.idc.2022.07.004_bib27","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","article-title":"Comparison of 8 vs 15\u00a0days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial","volume":"290","author":"Chastre","year":"2003","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.idc.2022.07.004_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041290","article-title":"Early-onset ventilator-associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15\u00a0days of antibiotic treatment","volume":"7","author":"Capellier","year":"2012","journal-title":"PloS one"},{"issue":"9","key":"10.1016\/j.idc.2022.07.004_bib29","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/cid\/cix986","article-title":"Duration of Antibiotic Use Among Adults With Uncomplicated Community-Acquired Pneumonia Requiring Hospitalization in the United States","volume":"66","author":"Yi","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2022.07.004_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7326\/M18-3640","article-title":"Excess Antibiotic Treatment Duration and Adverse Events in Patients Hospitalized With Pneumonia: A Multihospital Cohort Study","volume":"171","author":"Vaughn","year":"2019","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.idc.2022.07.004_bib31","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1093\/jac\/dku046","article-title":"Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis","volume":"69","author":"Feazel","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.idc.2022.07.004_bib32","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1086\/380964","article-title":"Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital","volume":"38","author":"Ruttimann","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2022.07.004_bib33","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1742-1241.2012.02999.x","article-title":"Outcome measurement of extensive implementation of antimicrobial stewardship in patients receiving intravenous antibiotics in a Japanese university hospital","volume":"66","author":"Niwa","year":"2012","journal-title":"Int J Clin Pract"},{"issue":"6","key":"10.1016\/j.idc.2022.07.004_bib34","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/phar.2118","article-title":"Shortened Courses of Antibiotics for Bacterial Infections: A Systematic Review of Randomized Controlled Trials","volume":"38","author":"Hanretty","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"9713","key":"10.1016\/j.idc.2022.07.004_bib35","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","article-title":"Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial","volume":"375","author":"Bouadma","year":"2010","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.idc.2022.07.004_bib36","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","article-title":"Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial","volume":"16","author":"de Jong","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2022.07.004_bib37","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1164\/rccm.201408-1483OC","article-title":"Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial","volume":"190","author":"Shehabi","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.idc.2022.07.004_bib38","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1097\/CCM.0b013e31821e8791","article-title":"Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial","volume":"39","author":"Jensen","year":"2011","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.idc.2022.07.004_bib39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.chest.2016.06.046","article-title":"Effect of Procalcitonin Testing on Health-care Utilization and Costs in Critically Ill Patients in the United States","volume":"151","author":"Balk","year":"2017","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.idc.2022.07.004_bib40","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/cid\/ciy917","article-title":"Procalcitonin-guided Antibiotic Treatment in Patients With Positive Blood Cultures: A Patient-level Meta-analysis of Randomized Trials","volume":"69","author":"Meier","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2022.07.004_bib41","doi-asserted-by":"crossref","first-page":"e533","DOI":"10.1093\/cid\/ciaa1239","article-title":"Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study","volume":"72","author":"Vaughn","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2022.07.004_bib42","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.cmi.2020.06.025","article-title":"Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting","volume":"26","author":"Hughes","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.idc.2022.07.004_bib43","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jac\/dkaa475","article-title":"An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London","volume":"76","author":"Wang","year":"2021","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.idc.2022.07.004_bib44","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/CCM.0000000000005297","article-title":"Increased Incidence of Ventilator-Acquired Pneumonia in Coronavirus Disease 2019 Patients: A Multicentric Cohort Study","volume":"50","author":"Vacheron","year":"2022","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.idc.2022.07.004_bib45","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.chest.2021.04.002","article-title":"Hospital-Acquired Infections in Critically Ill Patients With COVID-19","volume":"160","author":"Grasselli","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.idc.2022.07.004_bib46","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000005462","article-title":"Ventilator-Associated Lower Respiratory Tract Bacterial Infections in COVID-19 Compared With Non-COVID-19 Patients","author":"Hedberg","year":"2022","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.idc.2022.07.004_bib47","doi-asserted-by":"crossref","first-page":"ofab236","DOI":"10.1093\/ofid\/ofab236","article-title":"Trends in Antibiotic Use in United States Hospitals During the Coronavirus Disease 2019 Pandemic","volume":"8","author":"Rose","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2022.07.004_bib48","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s11739-021-02641-y","article-title":"Procalcitonin for the differential diagnosis of COVID-19 in the emergency department. Prospective monocentric study","volume":"16","author":"Nazerian","year":"2021","journal-title":"Intern Emerg Med"},{"issue":"1","key":"10.1016\/j.idc.2022.07.004_bib49","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12879-022-07144-5","article-title":"High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department","volume":"22","author":"Tong-Minh","year":"2022","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2022.07.004_bib50","first-page":"57","article-title":"Elevated Procalcitonin Is Positively Associated with the Severity of COVID-19: A Meta-Analysis Based on 10 Cohort Studies","author":"Shen","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.idc.2022.07.004_bib51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jhin.2021.01.006","article-title":"Evaluation of procalcitonin as a contribution to antimicrobial stewardship in SARS-CoV-2 infection: a retrospective cohort study","volume":"110","author":"Williams","year":"2021","journal-title":"The J Hosp Infect"},{"issue":"2","key":"10.1016\/j.idc.2022.07.004_bib52","doi-asserted-by":"crossref","first-page":"115344","DOI":"10.1016\/j.diagmicrobio.2021.115344","article-title":"Procalcitonin as a biomarker for ventilator associated pneumonia in COVID-19 patients: Is it an useful stewardship tool?","volume":"101","author":"Cortes","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2022.07.004_bib53","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.7861\/clinmed.2020-0614","article-title":"Use of procalcitonin for antibiotic stewardship in patients with COVID-19: A quality improvement project in a district general hospital","volume":"21","author":"Peters","year":"2021","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.idc.2022.07.004_bib54","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jgar.2020.07.017","article-title":"Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care unit","volume":"22","author":"Heesom","year":"2020","journal-title":"J\u00a0Glob Antimicrob Resist"},{"key":"10.1016\/j.idc.2022.07.004_bib55","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/1475-2875-8-206","article-title":"Procalcitonin as a biomarker for severe Plasmodium falciparum disease: a critical appraisal of a semi-quantitative point-of-care test in a cohort of travellers with imported malaria","volume":"8","author":"Hesselink","year":"2009","journal-title":"Malar J"},{"issue":"8","key":"10.1016\/j.idc.2022.07.004_bib56","doi-asserted-by":"crossref","first-page":"e0004961","DOI":"10.1371\/journal.pntd.0004961","article-title":"Serum Procalcitonin and Peripheral Venous Lactate for Predicting Dengue Shock and\/or Organ Failure: A Prospective Observational Study","volume":"10","author":"Thanachartwet","year":"2016","journal-title":"Plos Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.idc.2022.07.004_bib57","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13054-019-2481-y","article-title":"Procalcitonin levels in candidemia versus bacteremia: a systematic review","volume":"23","author":"Cortegiani","year":"2019","journal-title":"Crit Care"},{"issue":"12","key":"10.1016\/j.idc.2022.07.004_bib58","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/cid\/ciu732","article-title":"Use of procalcitonin in patients with various degrees of chronic kidney disease including renal replacement therapy","volume":"59","author":"Grace","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2022.07.004_bib59","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/1871526515666150320162950","article-title":"Lung cancer may increase serum procalcitonin level","volume":"15","author":"Avrillon","year":"2015","journal-title":"Infect Disord Drug Targets"},{"issue":"7","key":"10.1016\/j.idc.2022.07.004_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130999","article-title":"Role of Procalcitonin and Interleukin-6 in Predicting Cancer, and Its Progression Independent of Infection","volume":"10","author":"Chaftari","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.idc.2022.07.004_bib61","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11739-019-02156-7","article-title":"Procalcitonin in hemodialysis patients presenting with fever or chills to the emergency department","volume":"15","author":"Schneider","year":"2020","journal-title":"Intern Emerg Med"},{"issue":"1","key":"10.1016\/j.idc.2022.07.004_bib62","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/0886022X.2021.2021236","article-title":"Diagnostic value of procalcitonin for bacterial infections in patients undergoing hemodialysis: a systematic review and meta-analysis","volume":"44","author":"Tao","year":"2022","journal-title":"Ren Fail"},{"issue":"6","key":"10.1016\/j.idc.2022.07.004_bib63","doi-asserted-by":"crossref","first-page":"R160","DOI":"10.1186\/cc2372","article-title":"Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure","volume":"7","author":"Level","year":"2003","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.idc.2022.07.004_bib64","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s15010-021-01640-7","article-title":"Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?","volume":"49","author":"Soulountsi","year":"2021","journal-title":"Infection"},{"issue":"5","key":"10.1016\/j.idc.2022.07.004_bib65","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01909-17","article-title":"Diagnosing Invasive Candidiasis","volume":"56","author":"Clancy","year":"2018","journal-title":"J\u00a0Clin Microbiol"},{"issue":"11","key":"10.1016\/j.idc.2022.07.004_bib66","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.idc.2022.07.004_bib67","first-page":"142","article-title":"The Treatment of Lobar Pneumonia and Pneumococcal Empyema with Penicillin","volume":"20","author":"Tillett","year":"1944","journal-title":"Bull N Y Acad Med"},{"issue":"3","key":"10.1016\/j.idc.2022.07.004_bib68","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJMoa1802670","article-title":"Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection","volume":"379","author":"Huang","year":"2018","journal-title":"New Engl J Med"},{"key":"10.1016\/j.idc.2022.07.004_bib69","article-title":"Prevalence of Discordant Procalcitonin Use at an Academic Medical Center","author":"Seymann","year":"2021","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.idc.2022.07.004_bib70","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/cid\/ciy331","article-title":"Biomarkers of Sepsis and Bloodstream Infections: The Role of Procalcitonin and Proadrenomedullin With Emphasis in Patients With Cancer","volume":"67","author":"El Haddad","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2022.07.004_bib71","first-page":"9","article-title":"Complementary Use of Presepsin with the Sepsis-3 Criteria Improved Identification of High-Risk Patients with Suspected Sepsis","author":"Park","year":"2021","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.idc.2022.07.004_bib72","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1378\/chest.15-0123","article-title":"Prognostication of Mortality in Critically Ill Patients With Severe Infections","volume":"148","author":"Que","year":"2015","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.idc.2022.07.004_bib73","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1473-3099(16)30519-9","article-title":"A\u00a0host-protein based assay to differentiate between bacterial and viral infections in preschool children (OPPORTUNITY): a double-blind, multicentre, validation study","volume":"17","author":"van Houten","year":"2017","journal-title":"Lancet Infect Dis"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552022000551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552022000551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:31:05Z","timestamp":1760196665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552022000551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0891552022000551"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2022.07.004","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uses of Procalcitonin as a Biomarker in Critical Care Medicine","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2022.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}